Mexico - Latin America Defibrillator Market Size & Outlook
The defibrillator market in Mexico - Latin America is expected to reach a projected revenue of US$ 179.2 million by 2030. A compound annual growth rate of 7.9% is expected of Mexico - Latin America defibrillator market from 2024 to 2030.
In terms of revenue, Mexico accounted for 1.4% of the defibrillator market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Latin America, Brazil defibrillator market is projected to lead the regional market in terms of revenue in 2030.
Mexico is the fastest growing regional market in Latin America and is projected to reach USD 179.2 million by 2030.
Penetration of medical devices in Mexico is low due to the language barrier and low investment in healthcare. Mexico’s healthcare system is dominated by private players, and healthcare delivery through private entities in Mexico operates entirely as a free market.
According to the International Trade Administration, in 2021, around USD 5.9 billion worth of medical devices were imported into the country. For new entrants in the Mexican market, the Ministry of Health provides limited information about medical devices and IVDs in English; all the documentation must also be prepared in Spanish.
According to a study by the National Institute of Statistics and Geography, SCA in Mexico is the leading cause of death in people above 65 years is SCA in Mexico. The availability of PAD in Mexico is low. Thus it may be a potential market for companies planning to increase their geographical footprint.
Mexico - Latin America Defibrillator Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Defibrillator Market Outlook will help companies and investors design strategic landscapes.
Implantable Cardioverter Defibrillator (Icd) was the largest segment with a revenue share of 55.73% in 2023.
Horizon Databook has segmented the Mexico - Latin America defibrillator market based on implantable cardioverter defibrillator (icd), external defibrillator covering the revenue growth of each sub-segment from 2018 to 2030.
Penetration of medical devices in Mexico is low due to the language barrier and low investment in healthcare. Mexico’s healthcare system is dominated by private players, and healthcare delivery through private entities in Mexico operates entirely as a free market.
According to the International Trade Administration, in 2021, around USD 5.9 billion worth of medical devices were imported into the country. For new entrants in the Mexican market, the Ministry of Health provides limited information about medical devices and IVDs in English; all the documentation must also be prepared in Spanish.
According to a study by the National Institute of Statistics and Geography, SCA in Mexico is the leading cause of death in people above 65 years is SCA in Mexico. The availability of PAD in Mexico is low. Thus it may be a potential market for companies planning to increase their geographical footprint.
Mexico - Latin America Defibrillator Market Product Outlook (Revenue, USD Million , 2018-2030)
Implantable Cardioverter Defibrillator (ICD)
External Defibrillator
Mexico - Latin America Defibrillator Market end Use Outlook (Revenue, USD Million , 2018-2030)
Hospital
Pre hospital
Public Access market
Alternate care market
Home healthcare
Reasons to subscribe to Defibrillator Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Defibrillator Market Outlook databook
Our clientele includes a mix of Defibrillator Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico - Latin America Defibrillator Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Mexico - Latin America Defibrillator Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Mexico - Latin America Defibrillator Market, 2018-2030 (US$M)